Genetics and Genomics of Pulmonary Arterial Hypertension

• Muut tekijät: Southgate, Laura (Toimittaja), Machado, Rajiv (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Aiheet: Research & information: general; Genetics (non-medical); pulmonary arterial hypertension; massive parallel sequencing; NGS; digenic inheritance; and genetics; BMPR2 promoter; pathogenic variant; heritable pulmonary arterial hypertension; genetic analysis; NGS gene panel; BMPR2; TBX4; GDF2; EIF2AK4; genomics; pediatrics; lung disease; endothelial cells; smooth muscle cells; DNA damage; DNA repair; expression quantitative trait locus; eQTL; blood; genetics; exome sequencing; molecular genetics; paediatrics; bone morphogenetic protein receptor type 2; heritable; familial; estrogen; estradiol; penetrance; gender; PAH; forward phenotyping; forward genetics; reverse genetics; reverse phenotyping; intermediate phenotypes; whole-genome sequencing; epigenetic inheritance; genetic heterogeneity; phenotypic heterogeneity; pulmonary hypertension; bone morphogenetic protein receptor 2; signaling; repurposed drugs; pharmaceuticals; miRNA; clinical trials; n/a
• Linkit: DOAB: download the publication; DOAB: description of the publication

Pulmonary arterial hypertension is a severe and progressive disorder affecting the blood vessels in the lungs. Typically, symptoms first appear at around 30-40 years of age and, without treatment, can lead to fatal heart disease within a few years. Genetic studies over the past decade have identifie...